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The racemate medetomidine (MED), an alpha-2-adrenoceptor agonist, and its  
dextro-rotatory optical isomer dexmedetomidine (DEX) were studied in cats. The sedative effect of 
oral-mucosal application of MED and selected pharmacokinetic variables were evaluated and 
compared with intramuscular (I.M.) administration of the same dose of drug (n = 7). Sedative and 
analgesic effects of MED were also studied at different dose levels following either I.M. 
administration (n = 6) or continuous intravenous (I.V.) step infusion in cats (n = 6) and further 
compared with sedation and analgesia induced by equivalent doses of DEX (half the dose of MED). 
The effectiveness of using MED for post-operative pain relief in cats (n = 64) that had undergone 
ovariohysterectomy was evaluated and compared with butorphanol. The relationship between 
plasma and cerebrospinal fluid (CSF) concentrations of MED and how these concentrations vary 
with the levels of sedation in experimental rabbits (n = 23) were studied with the assumption that 
similar relationships may exist in cats.  
 
The results obtained indicated that oral-mucosal application of MED is effective for sedating cats 
and that when salivation and vomiting are minimal or absent, systemic drug availability and the 
extent of sedation are comparable between the oral-mucosal and I.M. routes. Maximum blood 
concentration of MED and clinical sedation are reached later with oral-mucosal application than 
with I.M. administration. Both MED and DEX induce dose-dependent sedation and analgesia in 
cats that reach ceiling doses, beyond which sedation may be reduced. DEX (at half the dose of 
MED) is as effective as MED for the sedation and analgesia of cats. The sedative and analgesic 
effects of MED in cats are mediated predominantly via its dextro-rotatory optical isomer. The levo-
rotatory isomer in MED may introduce some inconsistencies to the therapeutic effects of the drug at 
high doses and make the effects of MED unpredictable in terms of dose variation. The presence of 
the l-isomer in MED may not always be of therapeutic disadvantage. Intramuscularly administered 
MED relieves post-operative pain in cats, but it is not as potent as butorphanol. Serum 
concentration of MED predicts the concentration of MED in the CSF of rabbits. Increasing the 
concentration of MED in the CSF will not necessarily lead to an increase in the level of sedation. 
